Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5892368 | Bone | 2010 | 5 Pages |
Abstract
The use of AIs appears to lead to lower HSA-derived BMD and hip structural indices as compared to women on no or non-AI therapy in chemotherapy-induced postmenopausal breast cancer patients. Preventive therapy with once weekly oral risedronate maintains structural, skeletal integrity independently of the use of or type of adjuvant therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
G.J. van Londen, S. Perera, K.T. Vujevich, S.M. Sereika, R. Bhattacharya, S.L. Greenspan,